Cargando…

Days gained response discriminates treatment response in patients with recurrent glioblastoma receiving bevacizumab-based therapies

BACKGROUND: Accurate assessments of patient response to therapy are a critical component of personalized medicine. In glioblastoma (GBM), the most aggressive form of brain cancer, tumor growth dynamics are heterogenous across patients, complicating assessment of treatment response. This study aimed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singleton, Kyle W, Porter, Alyx B, Hu, Leland S, Johnston, Sandra K, Bond, Kamila M, Rickertsen, Cassandra R, De Leon, Gustavo, Whitmire, Scott A, Clark-Swanson, Kamala R, Mrugala, Maciej M, Swanson, Kristin R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Basic and Translational Investigations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447137/ https://www.ncbi.nlm.nih.gov/pubmed/32864609 http://dx.doi.org/10.1093/noajnl/vdaa085

Ejemplares similares

Assessment of Prognostic Value of Cystic Features in Glioblastoma Relative to Sex and Treatment With Standard-of-Care
por: Curtin, Lee, et al.
Publicado: (2020)

Shape matters: morphological metrics of glioblastoma imaging abnormalities as biomarkers of prognosis
por: Curtin, Lee, et al.
Publicado: (2021)

Image-based metric of invasiveness predicts response to adjuvant temozolomide for primary glioblastoma
por: Massey, Susan Christine, et al.
Publicado: (2020)

Sex-specific impact of patterns of imageable tumor growth on survival of primary glioblastoma patients
por: Whitmire, Paula, et al.
Publicado: (2020)

VEGF-C sustains VEGFR2 activation under bevacizumab therapy and promotes glioblastoma maintenance
por: Michaelsen, Signe R, et al.
Publicado: (2018)

Weakly Supervised Skull Stripping of Magnetic Resonance Imaging of Brain Tumor Patients
por: Ranjbar, Sara, et al.
Publicado: (2022)

Increased epithelial membrane protein 2 expression in glioblastoma after treatment with bevacizumab
por: Patel, Kunal S, et al.
Publicado: (2020)

Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice
por: de Groot, John F., et al.
Publicado: (2010)

The state of neuro-oncology during the COVID-19 pandemic: a worldwide assessment
por: Mrugala, Maciej M, et al.
Publicado: (2021)

Prognostic impact of PDGFRA gain/amplification and MGMT promoter methylation status in patients with IDH wild-type glioblastoma
por: Higa, Nayuta, et al.
Publicado: (2022)

Uncertainty quantification in the radiogenomics modeling of EGFR amplification in glioblastoma
por: Hu, Leland S., et al.
Publicado: (2021)

Single-cell image analysis reveals a protective role for microglia in glioblastoma
por: Woolf, Zoe, et al.
Publicado: (2021)

A mathematical modelling tool for predicting survival of individual patients following resection of glioblastoma: a proof of principle
por: Swanson, K R, et al.
Publicado: (2008)

Single-cell image analysis reveals over-expression of organic anion transporting polypeptides (OATPs) in human glioblastoma tissue
por: Cooper, Elizabeth, et al.
Publicado: (2022)

Detection of temozolomide-induced hypermutation and response to PD-1 checkpoint inhibitor in recurrent glioblastoma
por: Daniel, Paul, et al.
Publicado: (2022)

Longitudinal analysis of serum-derived extracellular vesicle RNA to monitor dacomitinib treatment response in EGFR-amplified recurrent glioblastoma patients
por: Yekula, Anudeep, et al.
Publicado: (2023)

A novel 3D human glioblastoma cell culture system for modeling drug and radiation responses
por: Gomez-Roman, Natividad, et al.
Publicado: (2017)

Radiation and adjuvant drug-loaded liposomes target glioblastoma stem cells and trigger in-situ immune response
por: Pizzocri, Marco, et al.
Publicado: (2021)

Discriminating Survival Outcomes in Patients with Glioblastoma Using a Simulation-Based, Patient-Specific Response Metric
por: Neal, Maxwell Lewis, et al.
Publicado: (2013)

GBMdeconvoluteR accurately infers proportions of neoplastic and immune cell populations from bulk glioblastoma transcriptomics data
por: Ajaib, Shoaib, et al.
Publicado: (2023)

In silico analysis suggests differential response to bevacizumab and radiation combination therapy in newly diagnosed glioblastoma
por: Hawkins-Daarud, Andrea, et al.
Publicado: (2015)

Tandem chimeric antigen receptor (CAR) T cells targeting EGFRvIII and IL-13Rα2 are effective against heterogeneous glioblastoma
por: Schmidts, Andrea, et al.
Publicado: (2022)

Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma
por: Wong, E T, et al.
Publicado: (2015)

Overexpression of ubiquitin-specific peptidase 15 in systemic sclerosis fibroblasts increases response to transforming growth factor β
por: Galant, Christine, et al.
Publicado: (2019)

Aberrant tRNA processing causes an autoinflammatory syndrome responsive to TNF inhibitors
por: Giannelou, Angeliki, et al.
Publicado: (2018)

Primary CNS lymphoma commonly expresses immune response biomarkers
por: Ou, Alexander, et al.
Publicado: (2020)

Cardiovascular MR T2-STIR imaging does not discriminate between intramyocardial haemorrhage and microvascular obstruction during the subacute phase of a reperfused myocardial infarction
por: Hansen, Esben Søvsø Szocska, et al.
Publicado: (2016)

Changes in contractile protein expression are linked to ventricular stiffness in infants with pulmonary hypertension or right ventricular hypertrophy due to congenital heart disease
por: Bond, Andrew R, et al.
Publicado: (2018)

Dysfunctional dendritic cells limit antigen-specific T cell response in glioma
por: Friedrich, Mirco, et al.
Publicado: (2022)

Heightened immune response to autocitrullinated Porphyromonas gingivalis peptidylarginine deiminase: a potential mechanism for breaching immunologic tolerance in rheumatoid arthritis
por: Quirke, Anne-Marie, et al.
Publicado: (2014)

Sox2(+) cells in Sonic Hedgehog-subtype medulloblastoma resist p53-mediated cell-cycle arrest response and drive therapy-induced recurrence
por: Treisman, Daniel M, et al.
Publicado: (2019)

Response to baricitinib based on prior biologic use in patients with refractory rheumatoid arthritis
por: Genovese, Mark C, et al.
Publicado: (2018)

Molecular changes underlying decay of sensory responses and enhanced seizure propensity in peritumoral neurons
por: Tantillo, Elena, et al.
Publicado: (2023)

Proteins inform survival-based differences in patients with glioblastoma
por: Stetson, L C, et al.
Publicado: (2020)

Identification of five important genes to predict glioblastoma subtypes
por: Tang, Yang, et al.
Publicado: (2021)

PELP1 promotes glioblastoma progression by enhancing Wnt/β-catenin signaling
por: Sareddy, Gangadhara R, et al.
Publicado: (2019)

The histamine H(4) receptor mediates inflammation and Th17 responses in preclinical models of arthritis
por: Cowden, Jeffery M, et al.
Publicado: (2014)

Exacerbated inflammatory arthritis in response to hyperactive gp130 signalling is independent of IL-17A
por: Jones, G W, et al.
Publicado: (2013)

Tumor volumes as a predictor of response to the anti-EGFR antibody drug conjugate depatuxizumab mafadotin
por: Gan, Hui K, et al.
Publicado: (2021)

Notch signalling pathways mediate synovial angiogenesis in response to vascular endothelial growth factor and angiopoietin 2
por: Gao, Wei, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_li7aihlcs8u2r3734eq1el4cbg